Nucleome Therapeutics Limited
- Company number
- 12109297
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 17 Jul 2019
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (48458 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BODMER, Mark | Director | 24 Jul 2024 | |
| DAVIS, John | Director | 15 Feb 2024 | |
| GREIG, Russell George, Dr | Director | 6 Sep 2023 | |
| AL-HALLAQ, Rana Abdul Raouf, Dr | Director | 21 Oct 2022 | |
| ANNINGA, Bauke, Dr | Director | 21 Oct 2022 | |
| HEPPLE, Jonathan Paul, Dr | Director | 30 Nov 2020 | |
| HUGHES, James Raymond | Director | 17 Jul 2019 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Oxford Science Enterprises Plc | Voting Rights 25 To 50 Percent | 2 Aug 2019 | |
| James Raymond Hughes | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
17 Jul 2019 | 29 Jul 2019 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | - | £7,662,121 | 44 |
| 31 Dec 2024 | - | - | - |
| 31 Jul 2024 | - | - | - |
| 31 Jul 2023 | - | - | - |
| 31 Jul 2022 | - | - | - |
| 31 Jul 2021 | - | - | - |
| 31 Jul 2020 | £4,659,071 | £4,379,889 | 4 |
Connections
Owned by
Nucleome Therapeutics Limited → Oxford Science Enterprises PLC
Directors’ other companies
- AL-HALLAQ, Rana Abdul Raouf, Dr - Director at Enara Bio Limited
- HEPPLE, Jonathan Paul, Dr - Director at Rosetta Capital V Gp Limited
- HEPPLE, Jonathan Paul, Dr - Director at Rosetta Partners Limited